-
Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary SyndromeG Pemmasani, I Elgendy, MA Mamas et al. -
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al.
-
From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary SyndromesSzummer K, Jernberg T, Wallentin L.
-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
-
Coronary CT Angiography and 5-Year Risk of Myocardial InfarctionThe SCOT-HEART Investigators.
-
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary AngiographyRHM Furtado, JC Nicolau, JP Guo et al.
-
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)J-P Collet, H Thiele, E Barbato et al.
-
Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial InfarctionN Haider, L Boscá, HR Zandbergen et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
